Investor Presentaiton
Our positioning
A
+
Customer segments &
ROI
Clinical trials
& RWE
$53B industry
5% CAGR
Priced from
$1 - $29
Health & Life
Insurance
$5T industry,
3% CAGR²
Payor ROI - why customers buy dHaaS:
1. Reduced cost and risk (through early
detection and intervention opportunities)
2. Improved health and care outcomes
3. Process automation (HR, health care
providers)
4. Data - better understand customer needs,
improving sales of core goods/services better
Government
Dept's & Ministry of
Health
$16T industry
9% CAGR4,5
Healthcare
providers
$11T industry
9% CAGR³
Investor Presentation - January 2024
Sources
1. https://www.globenewswire.com/en/news-
release/2022/04/11/2420173/0/en/Worldwide-3-Trillion-Health-Insurance-Market-Size-is-
Expected-to-Grow-at-a-CAGR-of-over-4-4-During-2022-2028-Vantage-Market-
Research.html
2. https://www.mordorintelligence.com/industry-reports/global-life-and-non-life-insurance-
market--growth-trends-and-forecast-2020---2025
3. https://www.businesswire.com/news/home/20190625005862/en/The-11.9-Trillion-
Global-Healthcare-Market-Key-Opportunities-Strategies-2014-2022---
ResearchAndMarkets.com
4. https://stats.oecd.org/Index.aspx?DataSetCode=SHA
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695957/
21View entire presentation